Загрузка...
Oral Thrombostatin FM19 Inhibits Prostate Cancer
Thrombin stimulates proliferation, invasion and metastasis by cleaving PAR1 on a human prostate cancer cells. Current direct thrombin inhibitors pose risks for bleeding in the cancer patients. We have developed an oral reversible direct thrombin inhibitor called FM19. FM19 inhibits thrombin-induced...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3552554/ https://ncbi.nlm.nih.gov/pubmed/20886199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH09-08-0570 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|